+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Precision Medicine Market - Global Forecast 2026-2032- Product Image
Precision Medicine Market - Global Forecast 2026-2032- Product Image
Sale

Precision Medicine Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968722
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Precision Medicine Market is projected to reach USD 152.68 Billion in 2026. It is expected to continue growing at a CAGR of 13.34%, reaching USD 324.92 Billion by 2032.

Precision medicine is redefining healthcare by matching prevention, diagnosis, and treatment to the biological, environmental, and lifestyle characteristics of each patient. The market is advancing from broad population-based care toward biomarker-driven therapies, genomic testing, companion diagnostics, pharmacogenomics, molecular imaging, and data-enabled clinical decision support.

Adoption is strongest in oncology, rare diseases, immunology, cardiology, neurology, and infectious disease management, where validated biomarkers increasingly guide therapy selection and monitoring. Public programs such as NIH All of Us, the UK 100,000 Genomes Project, Genome India, national genome initiatives in the Gulf, and the European 1+ Million Genomes framework demonstrate that precision medicine is now a strategic priority for health systems, life sciences companies, diagnostics developers, payers, and digital health providers.

Transformative Shifts in Precision Medicine

The precision medicine landscape is shifting from isolated genetic tests to integrated multi-omics, real-world evidence, electronic health records, imaging, wearable data, and longitudinal patient monitoring. Next-generation sequencing, liquid biopsy, decentralized clinical trials, and companion diagnostics are accelerating earlier detection and more targeted treatment pathways.

Regulatory and reimbursement models are also evolving. Agencies such as the FDA and EMA support biomarker-based drug development, while payers increasingly require clinical utility, health economic evidence, and equitable access strategies. Industry leaders are responding with cloud-based data platforms, privacy-preserving analytics, adaptive trial designs, and partnerships among biopharma, hospitals, laboratories, academic centers, and technology providers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across precision medicine by helping researchers detect patterns in genomics, transcriptomics, proteomics, pathology, radiology, claims data, and clinical notes. AI-enabled models support variant interpretation, patient stratification, drug target discovery, trial matching, adverse event prediction, and treatment response forecasting when validated against high-quality clinical evidence.

The greatest impact is emerging where AI is combined with curated datasets, transparent model governance, and clinician oversight. Federated learning, synthetic data, and privacy-enhancing technologies are helping organizations collaborate without exposing sensitive patient information. However, successful deployment depends on bias testing, regulatory alignment, explainability, cybersecurity, and continuous monitoring to ensure that AI improves precision medicine outcomes rather than amplifying health disparities.

Key Regional Insights

North America remains a leading precision medicine region due to mature genomics infrastructure, FDA-recognized biomarker pathways, strong biopharma investment, and large research networks in the United States and Canada. Europe is advancing through cross-border genomics initiatives, national sequencing programs, strong academic medicine, and GDPR-driven data governance, with the European Union supporting health data interoperability through initiatives such as the European Health Data Space and the 1+ Million Genomes framework.

Asia-Pacific is scaling quickly as China, Japan, India, South Korea, Australia, and ASEAN markets expand genomic medicine, oncology diagnostics, population health programs, and digital hospital infrastructure. Latin America, led by Brazil and Mexico, is building capacity through cancer genomics, academic networks, biobanking, and private laboratory expansion. The Middle East is accelerating through national genome programs in GCC countries, precision oncology centers, and government-led digital health investment, while Africa is gaining momentum through infectious disease genomics, sickle cell research, newborn screening, and partnerships focused on improving African representation in global genomic datasets.

Key Group Insights

ASEAN is becoming a practical growth corridor for precision medicine as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines strengthen genomics, digital health, laboratory accreditation, and clinical research capabilities at different maturity levels. The GCC is distinguished by government-backed genome programs, strong hospital investment, national AI strategies, and population health initiatives in Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets.

The European Union provides scale through data protection standards, cross-border biomedical research, regulatory alignment, and the European Health Data Space agenda. BRICS countries offer large, genetically diverse populations, expanding sequencing capacity, and growing biomanufacturing capabilities, while the G7 leads in regulatory science, advanced diagnostics, AI governance, health data standards, and biopharma innovation. NATO countries are also relevant through health security, bio-surveillance, cybersecurity, pandemic preparedness, and resilient medical supply chains that support precision medicine infrastructure.

Key Country Insights

The United States leads through NIH-funded research, FDA biomarker guidance, academic medical centers, commercial genomic testing, and strong biopharma pipelines. Canada is advancing precision health through provincial genomics programs, pan-Canadian research networks, and population health data assets, while Mexico is expanding access through oncology diagnostics, laboratory modernization, and public-private clinical collaborations. Brazil is the Latin American anchor for genomic research, cancer care innovation, and rare disease investigation.

In Europe, the United Kingdom benefits from NHS-linked genomics and national sequencing experience, Germany from precision oncology, engineering depth, and clinical research strength, France from national genomic medicine planning and cancer research networks, Italy and Spain from strong clinical networks and regional genomic programs, and Russia from domestic biomedical research despite access and collaboration constraints. In Asia-Pacific, China is scaling sequencing, oncology innovation, and hospital-based genomics; India is expanding Genome India, biobank development, and cost-efficient diagnostics; Japan is strong in regenerative medicine, oncology, and pharmacogenomics; Australia has leading genomic medicine programs and strong rare disease initiatives; and South Korea combines hospital digitization, sequencing, AI-enabled healthcare, and biopharma investment.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical utility, not technology adoption alone. Successful precision medicine strategies require validated biomarkers, interoperable data architecture, quality-controlled testing, physician education, payer evidence, and measurable patient outcomes across diverse populations.

Organizations should build partnerships across biopharma, diagnostics, providers, payers, regulators, and technology specialists. Near-term priorities include investing in AI-ready data governance, expanding companion diagnostic access, designing inclusive clinical trials, strengthening cybersecurity, demonstrating cost-effectiveness, and aligning product development with regulatory expectations for biomarker evidence and real-world performance.

Research Methodology

This executive summary is developed from verified secondary research and structured industry analysis using public regulatory resources, clinical trial registries, government genome program updates, peer-reviewed literature, health agency publications, policy documents, and recognized public healthcare datasets. Sources considered include FDA, EMA, NIH, the European Commission, national genomics programs, clinical guideline repositories, and publicly available precision medicine policy documents.

Insights are triangulated across technology adoption, regulatory direction, clinical use cases, investment activity, regional infrastructure, reimbursement readiness, and health data governance. The methodology emphasizes data reliability, source credibility, recency, and cross-validation to ensure that conclusions reflect measurable precision medicine developments rather than speculative claims.

Conclusion

Precision medicine is moving from an innovation niche to a core healthcare model supported by genomics, AI, companion diagnostics, real-world evidence, and increasingly connected health data ecosystems. The strongest opportunities will emerge where scientific validation, regulatory confidence, reimbursement clarity, clinical workflow integration, and equitable patient access converge.

For industry stakeholders, the next phase will be defined by scalable clinical implementation. Organizations that combine high-quality data, validated biomarkers, responsible AI, inclusive research, and cross-sector partnerships will be best positioned to strengthen adoption across the global precision medicine landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Precision Medicine Market, by Product Type
7.1. Introduction
7.2. Diagnostics
7.2.1. Companion Diagnostics
7.2.2. Genetic Testing
7.2.3. Liquid Biopsy
7.2.4. Molecular Diagnostics
7.2.5. Point-of-Care Testing
7.3. Software & Data Analytics
7.4. Therapeutics
7.4.1. Cell Therapy
7.4.2. Gene Therapy
7.4.3. Immunotherapy
7.4.4. Protein Replacement Therapy
7.4.5. RNA-Based Therapy
7.4.6. Targeted Therapy
8. Precision Medicine Market, by Biomarker Type
8.1. Introduction
8.2. Genomic Biomarkers
8.3. Proteomic Biomarkers
8.4. Metabolomic Biomarkers
8.5. Epigenetic Biomarkers
9. Precision Medicine Market, by Route of Administration
9.1. Introduction
9.2. Oral
9.3. Injectable
9.4. Intravenous
9.5. Subcutaneous
10. Precision Medicine Market, by Application
10.1. Introduction
10.2. Autoimmune Diseases
10.3. Cardiology
10.4. Infectious Diseases
10.5. Neurology
10.6. Oncology
10.7. Rare & Genetic Disorders
10.8. Respiratory Diseases
11. Precision Medicine Market, by End User
11.1. Introduction
11.2. Biopharmaceutical & Biotechnology Companies
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Research Institutes
12. Precision Medicine Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Precision Medicine Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Precision Medicine Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Amgen Inc.
16.3. Aranscia, LLC
16.4. AstraZeneca PLC
16.5. biocrates life sciences ag
16.6. bioMérieux S.A.
16.7. Bristol-Myers Squibb Company
16.8. Caris Life Sciences
16.9. Exact Sciences Corporation
16.10. F. Hoffmann-La Roche AG
16.11. Gilead Sciences, Inc.
16.12. Guardant Health, Inc.
16.13. healthOme, Inc.
16.14. Hitachi High-Tech Corporation
16.15. Illumina, Inc.
16.16. Johnson & Johnson
16.17. Laboratory Corporation of America Holdings
16.18. Medtronic PLC
16.19. Merck KGaA
16.20. N-Power Medicine, Inc.
16.21. Natera Inc.
16.22. NeoGenomics, Inc.
16.23. Novartis AG
16.24. Pfizer, Inc.
16.25. Precision Medicine Group, LLC
16.26. QIAGEN N.V.
16.27. Quest Diagnostics Incorporated
16.28. Sanofi SA
16.29. Strata Oncology, Inc.
16.30. Tempus AI, Inc.
16.31. Teva Pharmaceutical Industries Ltd.
16.32. Thermo Fisher Scientific Inc.
16.33. ZS Associates, Inc.
List of Figures
FIGURE 1. GLOBAL PRECISION MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PRECISION MEDICINE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PRECISION MEDICINE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PRECISION MEDICINE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PRECISION MEDICINE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LIQUID BIOPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LIQUID BIOPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SOFTWARE & DATA ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SOFTWARE & DATA ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SOFTWARE & DATA ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PROTEIN REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PROTEIN REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PROTEIN REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL RNA-BASED THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL RNA-BASED THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL RNA-BASED THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TARGETED THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TARGETED THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TARGETED THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL GENOMIC BIOMARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL GENOMIC BIOMARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL GENOMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PROTEOMIC BIOMARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PROTEOMIC BIOMARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PROTEOMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL METABOLOMIC BIOMARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL METABOLOMIC BIOMARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL METABOLOMIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL EPIGENETIC BIOMARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL EPIGENETIC BIOMARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL EPIGENETIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL RARE & GENETIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL RARE & GENETIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL RARE & GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL PRECISION MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. EUROPE PRECISION MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. EUROPE PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 118. EUROPE PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 119. EUROPE PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 120. EUROPE PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 121. EUROPE PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 122. EUROPE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. EUROPE PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. AFRICA PRECISION MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. AFRICA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 142. AFRICA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 143. AFRICA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 144. AFRICA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 145. AFRICA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 146. AFRICA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. AFRICA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PRECISION MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. NATO PRECISION MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. NATO PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 159. NATO PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 160. NATO PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 161. NATO PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 162. NATO PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 163. NATO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. NATO PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. G7 PRECISION MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. G7 PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. G7 PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 168. G7 PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 169. G7 PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 170. G7 PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 171. G7 PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. G7 PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. BRICS PRECISION MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. BRICS PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 175. BRICS PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 176. BRICS PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 177. BRICS PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 178. BRICS PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 179. BRICS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. BRICS PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. ASEAN PRECISION MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. ASEAN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. ASEAN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 192. ASEAN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 193. ASEAN PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 194. ASEAN PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 195. ASEAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 196. ASEAN PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. GCC PRECISION MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. GCC PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. GCC PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 200. GCC PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 201. GCC PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 202. GCC PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 203. GCC PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 204. GCC PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 206. CHINA PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. CHINA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. CHINA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 209. CHINA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 210. CHINA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 211. CHINA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 212. CHINA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. CHINA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 217. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. JAPAN PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 223. JAPAN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 224. JAPAN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 225. JAPAN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 226. JAPAN PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 227. JAPAN PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 228. JAPAN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 229. JAPAN PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. INDIA PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. INDIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. INDIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 233. INDIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 234. INDIA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 235. INDIA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 236. INDIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. INDIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. GERMANY PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. GERMANY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. GERMANY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 241. GERMANY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 242. GERMANY PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 243. GERMANY PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 244. GERMANY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. GERMANY PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 251. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 252. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. UNITED KINGDOM PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. AUSTRALIA PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 257. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 258. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 259. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 260. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. AUSTRALIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. FRANCE PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 263. FRANCE PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 264. FRANCE PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 265. FRANCE PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 266. FRANCE PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 267. FRANCE PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 268. FRANCE PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. FRANCE PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 272. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 273. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 274. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 275. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 276. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 277. SOUTH KOREA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. ITALY PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. ITALY PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. ITALY PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 281. ITALY PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 282. ITALY PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 283. ITALY PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 284. ITALY PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 285. ITALY PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. CANADA PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. CANADA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 288. CANADA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 289. CANADA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 290. CANADA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 291. CANADA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 292. CANADA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 293. CANADA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. RUSSIA PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 310. MEXICO PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 311. MEXICO PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 312. MEXICO PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 313. MEXICO PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 314. MEXICO PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 315. MEXICO PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 316. MEXICO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 317. MEXICO PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. SPAIN PRECISION MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 319. SPAIN PRECISION MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 320. SPAIN PRECISION MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 321. SPAIN PRECISION MEDICINE MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 322. SPAIN PRECISION MEDICINE MARKET SIZE, BY BIOMARKER TYPE, 2017-2032 (USD MILLION)
TABLE 323. SPAIN PRECISION MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 324. SPAIN PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 325. SPAIN PRECISION MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. GLOBAL PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 327. GLOBAL PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • AbbVie Inc.
  • Amgen Inc.
  • Aranscia, LLC
  • AstraZeneca PLC
  • biocrates life sciences ag
  • bioMérieux S.A.
  • Bristol-Myers Squibb Company
  • Caris Life Sciences
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • Guardant Health, Inc.
  • healthŌme, Inc.
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Merck KGaA
  • N-Power Medicine, Inc.
  • Natera Inc.
  • NeoGenomics, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Precision Medicine Group, LLC
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Strata Oncology, Inc.
  • Tempus AI, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • ZS Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 152.68 Billion
Forecasted Market Value ( USD ) by 2032 $ 324.92 Billion
Compound Annual Growth Rate13.3%
Regions CoveredGlobal
No. of Companies Mentioned34

Related Topics

Related Reports

Oncology Precision Medicine Market - Global Forecast 2026-2032 - Product Image

Oncology Precision Medicine Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Precision Medicine - Global Strategic Business Report - Product Image

Precision Medicine - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
AI in Precision Medicine - Global Strategic Business Report - Product Image

AI in Precision Medicine - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
AI in Precision Medicine Market (By Technology, Component, Application and Geography), Key Company Profiles, Recent Developments, and Market Dynamics - Forecast to 2032 - Product Image

AI in Precision Medicine Market (By Technology, Component, Application and Geography), Key Company Profiles, Recent Developments, and Market Dynamics - Forecast to 2032

  • Report
  • 143 Pages
  • Global
From
Precision Medicine Software Market Forecast to 2033 - Product Image

Precision Medicine Software Market Forecast to 2033

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.